Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

Nature

Volumn 436, Issue 7052, 2005, Pages 807-811

  Hemann, Michael T ^a   Bric, Anka ^a   Teruya Feldstein, Julie ^b   Herbst, Andreas ^a   Nilsson, Jonas A ^c   Cordon Cardo, Carlos ^b   Cleveland, John L ^c   Tansey, William P ^a   Lowe, Scott W ^a,d  

^a Simons Center for Quantitative Biology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; MUTAGENESIS; TUMORS;

ALLELES; APOPTOSIS; STIMULATE PROLIFERATION; TUMORIGENESIS;

PROTEINS;

BIM PROTEIN; MUTANT PROTEIN; MYC PROTEIN; PROTEIN BCL 2; TUMOR PROTEIN;

MEDICINE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENETIC TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR ESCAPE; TUMOR SUPPRESSOR GENE;

ADOPTIVE TRANSFER; ALLELES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BURKITT LYMPHOMA; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENES, MYC; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; STEM CELL TRANSPLANTATION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 23844469503     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03845     Document Type: Article

References (30)

1. Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1-11 (1999).
2. Cole, M. D. Activation of the c-myc oncogene. Basic Life Sci. 38, 399-406 (1986).
3. Spencer, C. A. & Groudine, M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1-48 (1991).
4. Dalla-Favera, R. et al. Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824-7827 (1982).
5. Davis, M., Malcolm, S. & Rabbitts, T. H. Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells. Nature 308, 286-288 (1984).
6. Bhatia, K. et al. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genet. 5, 56-61 (1993).
7. Albert, T., Urlbauer, B., Kohlhuber, F., Hammersen, B. & Eick, D. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9, 759-763 (1994).
8. Clark, H. M. et al. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res. 54, 3383-3386 (1994).
9. Henriksson, M., Bakardjiev, A., Klein, G. & Luscher, B. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8, 3199-3209 (1993).
10. Hoang, A. T. et al. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15, 4031-4042 (1995).
11. Westaway, D., Payne, G. & Varmus, H. E. Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. Proc. Natl Acad. Sci. USA 81, 843-847 (1984).
12. Salghetti, S. E., Kim, S. Y. & Tansey, W. P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726 (1999).
13. Chang, D. W., Claassen, G. F., Hann, S. R. & Cole, M. D. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20, 4309-4319 (2000).
14. Sears, R. C. The life cycle of c-Myc: from synthesis to degradation. Cell Cycle 3, 1133-1137 (2004).
15. Frykberg, L., Graf, T. & Vennstrom, B. The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene 1, 415-422 (1987).
16. Yen, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308-318 (2004).
17. Rabbitts, T. H., Hamlyn, P. H. & Baer, R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 306, 760-765 (1983).
18. Bemark, M. & Neuberger, M. S. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene 19, 3404-3410 (2000).
19. Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533-538 (1985).
20. Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
21. Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77-83 (2003).
22. Maclean, K. H., Keller, U. B., Rodriguez-Galindo, C., Nilsson, J. A. & Cleveland, J. L. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol. Cell. Biol. 23, 7256-7270 (2003).
23. Seoane, J., Le, H. V. & Massague, J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002).
24. Egle, A., Harris, A. W., Bouillet, P. & Cory, S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl Acad. Sci. USA 101, 6164-6169 (2004).
25. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).
26. Schmitt, C. A. et al. Dissecting p53 tumour suppressor functions in vivo. Cancer Cell 1, 289-298 (2002).
27. Gaidano, G. et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 88, 5413-5417 (1991).
28. Bhatia, K. G., Gutierrez, M. I., Huppi, K., Siwarski, D. & Magrath, I. T. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res. 52, 4273-4276 (1992).
29. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
30. Yu, D. & Thomas-Tikhonenko, A. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene 21, 1922-1927 (2002).